2.Early assessment of the level of serum cystatin C to renal damage in patients with multiple myeloma
Lingling SUN ; Yanli MENG ; Guangyu SONG ; Jingjing HU ; Bin JI
Chinese Journal of Postgraduates of Medicine 2014;37(25):56-58
Objective According to the level of serum cystatin C (Cys-C)in patients with multiple myeloma (MM),to explore its significance of early assessment to renal damage.Methods To select 42 patients with MM(MM group) and 30 healthy subjects(control group),and measure serum Cys-C,creatinine (SCr) and β2-microglobulin (β2-MG).Results The level of serum Cys-C in MM group was significantly higher than that in control group [(2.34 ± 0.57) mg/L vs.(0.66 ± 0.12) mg/L],which increased with ISS stage[Ⅰ,Ⅱ,Ⅲ stage was(1.77 ± 0.38),(2.11 ± 0.46),(3.14-± 1.07) mg/L](P< 0.05).Cys-C and β 2-MG,renal function had a positive correlation (r =0.760,0.694,P < 0.05).Conclusion The increasing of Cys-C in MM patients is related to impaired renal function and tumor burden,which can be used as an early assessment indicators.
3.Puerarin Inhibits Inductible Nitric Oxide Synthase expression in Lipopolysaccharide -induced RAW264.7 Macrophage Cells
Jian YU ; Wenzhi HU ; Ling JI ; Lie SUN
Chinese Journal of Rehabilitation Theory and Practice 2010;16(9):835-836
ObjectiveTo investigate the effect of Puerarin on expression of inductible nitric oxide synthase (iNOS) in RAW264.7 macrophage cells induced by lipopolysaccharide (LPS). MethodsThe protein and mRNA levels of lipopolysaccharide (LPS)-induced iNOS was determined in RAW264.7 macrophage cells using Western blotting and RT-PCR respectively. ResultsPuerarin inhibited expression of iNOS concentration dependently (P<0.01). ConclusionPuerarin may reduce iNOS level, result in prevention of inflammation.
4.LRP gene expression and its clinical significance in childhood acute leukemia.
Xiao-bin HU ; Wan-ru HU ; Cheng-ji GUO ; Zhi-gang SUN ; Min WANG
Chinese Journal of Pediatrics 2003;41(12):953-954
Acute Disease
;
Adolescent
;
Child
;
Child, Preschool
;
Drug Resistance, Multiple
;
genetics
;
Drug Resistance, Neoplasm
;
genetics
;
Female
;
Gene Expression Regulation, Neoplastic
;
Humans
;
Leukemia
;
physiopathology
;
Male
;
Neoplasm Proteins
;
genetics
;
RNA, Messenger
;
genetics
;
metabolism
;
Reverse Transcriptase Polymerase Chain Reaction
;
Vault Ribonucleoprotein Particles
;
genetics
5.The preliminary analysis of peripheral blood microRNA expression profile of gastric cancer
Wei GU ; Meijie HU ; Ying SUN ; Ji WANG ; Xiaoying HU ; Jin MA
Chinese Journal of Digestion 2012;32(4):222-225
Objective To explore the peripheral blood microRNA (miRNA) expression of patients with gastric cancer,and to establish specific peripheral blood miRNA expression profile of gastric cancer,which would provide the evidencc for investigating the role of miRNA in the genesis and development of gastric cancer and looking for new molecular markers of gastric cancer.MethodsA total of 6 gastric cancer patients and 6 healthy volunteers were selected.The totat RNA of peripheral blood was extracted for miRNA expression profile examination and hioinformation analysis. The results of microarray were verified by real-time PCR. The online miRNA target gene pr(e)diction software was used to predict and screen miRNA differentially expressed target genes. Results Compared with control group,there were 54 differentially expressed miRNA in gastric cancer group,of which the expression of 35 miRNA (miRNA-504,mi RNA-183,miRNA- 938,miRNA-1285,miRNA- 576-3p,miRNA-663,etc) were up-regulated and 19 miRNA (miRNA-433,miRNA-193b,miRNA-329,miRNA 409-3p,miRNA 154,el(e)) were down-regulated.The results of real-time PCR indicated that there was a good consistency between PCR verificd results and microarray results in 2 up-regulated miRNA (miRNA 504 and miRNA-183) and 2 down-regulated miRNA (miRNA-443 and miRNA- 193b).ConclusionThere is specific peripheral blood miRNA expression profile of patients with gastric cancer,and these differentially cxpressed miRNA will likely become new diagnostic biomarkers of gastric cancer.
6.Identification of a new sildenafil analogue based on Q-TOF-MS.
Jian SUN ; Hong YU ; Qing HU ; Rui FENG ; Su ZHANG ; Shen JI
Acta Pharmaceutica Sinica 2014;49(4):513-516
The drugs such as sildenafil adulterated in herbal products and dietary supplements may endanger human health. The number of the new modified derivatives is increasing recently. Based on Q-TOF-MS, a new sildenafil analogue was found. It was isolated and purified by preparative liquid chromatography. Its structure was determined by NMR, as 1-[4-propoxy-3-(6, 7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4, 3-d] pyrimidin-5-yl)phenylsulfonyl]-4-methylpiperazine. Compared with sildenafil, the ethoxy group of the benzene ring moiety was moved to the propoxy group, which had not been reported in China. The mass spectrometric behavior pattern of the structure type was summarized, which can greatly accelerate the structural analysis of novel analogues.
Chromatography, High Pressure Liquid
;
Dietary Supplements
;
analysis
;
Drug Contamination
;
Magnetic Resonance Spectroscopy
;
Molecular Structure
;
Piperazines
;
chemistry
;
isolation & purification
;
Sildenafil Citrate
;
chemistry
;
Spectrometry, Mass, Electrospray Ionization
7.Value of cerebrospinal fluid leukocyte aggregation score in distinguishing the causes of meningitis.
Rui-mei HU ; Ruo-peng SUN ; Shu-hua GUO ; Bao-min LI ; Ji-wen WANG
Chinese Journal of Pediatrics 2003;41(6):463-465
Adolescent
;
C-Reactive Protein
;
metabolism
;
Cell Aggregation
;
Child
;
Child, Preschool
;
Cytodiagnosis
;
methods
;
Female
;
Humans
;
Infant
;
Leukocytes
;
cytology
;
Male
;
Meningitis, Bacterial
;
blood
;
cerebrospinal fluid
;
diagnosis
;
Meningitis, Viral
;
blood
;
cerebrospinal fluid
;
diagnosis
;
Sensitivity and Specificity
8.Safety evaluation of Dengzhanxixin injection in 986 elderly inpatients
Liwei JI ; Bing ZHOU ; Yatong ZHANG ; Jun ZHANG ; Xin LIN ; Qian NI ; Xin HU ; Chunhua SUN
Chinese Journal of Geriatrics 2009;28(9):715-718
Objective To investigate the rationality and safety of dengzhanxixin injection used in elderly inpatients. Methods The clinical data of 986 inpatients including 620 males and 366 females were collected, and questionnaires containing age, sex, discharge diagnosis, symptoms, drug dosage, course of treatment, laboratory examination, adverse drug reaction and drug effect were analyzed. Results For the 986 cases, the average age was(74.3±7.5)years. The average dose of dengzhanxixin injection was (38.2±4.4) ml, once daily by intravenous drip, and the average period of treatment was (10.8±5.2) days. The adverse reaction rate was 0.81%. The levels of blood glucose and hemoglobin were decreased after treatment(t orμ=1226.5,2620.0, both P<0.05), but there were no statistical differences in the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine (CREA), blood urea nitrogen (BUN) and white blood cell count (WBC) before and after treatment (t or μ=122.5, 405.0, 513.5, 996.5, 956.5, all P>0.05). Conclusions It is safe to use dengzhanxixin injection according to the medication description for elderly inpatients.
9.Application of intervention bundles in enteral nutrition for patients with esophageal cancer
Dafu XU ; Wenze TIAN ; Jian JI ; Zhongwu HU ; Zhenbing YOU ; Wei GUO ; Yongjian SUN
Chinese Journal of Clinical Nutrition 2017;25(3):171-175
Objective To investigate the value of intervention bundles in enteral nutrition for patients with esophageal cancer.Methods From October 2014 to September 2015,226 patients with esophageal squamous cell carcinoma were collected.From April 2015 to September 2015,109 patients(intervention group)were treated with intervention bundles during perioperative period,and from October 2014 to March 2015,117 patients(control group)were treated by routine intervention.Results The albumin,prealbumin,and transferrin showed no significant difference(all P>0.05)before treatment but were significantly different on the eighth day[albumin:(38.2±3.5)g/L vs.(36.3±4.8)g/L,P=0.001;prealbumin:(126.7±52.8)g/L vs.(72.9±42.3)g/L,P=0.001;transferrin:(2.9±1.2)g/L vs.(2.1±1.6)g/L,P=0.001].The incidence of complications was 11.01%(12/109)in intervention group and 21.37%(25/117)in control group(X2=4.422,P=0.035).In addition,the postoperative exhaust time[(52.8±10.9)h vs.(58.7±14.3)h,P=0.001],time to the removal of chest drainage tube[(3.5±0.9)d vs.(4.8±1.3)d,P=0.001],postoperative hospital stay[(11.2±1.3)d vs.(12.1±1.5)d,P=0.001],and hospital costs[(37±4)thousand yuan vs.(39±5)thousand yuan,P=0.004] were also significantly shorter or smaller in the intervention group.Conclusions Intervention bundles is clinically valuable in the early enteral nutrition for patients with esophageal cancer.It can improve the nutritional status of patients,reduce complications,and improve the clinical outcomes.
10.Ultrasound guided popliteal vein catheter thrombolysis for acute lower extremity deep venous thrombosis
Weiqing HU ; Bo SUN ; Changan PEI ; Wuguang JI ; Guangxin CAO ; Jiefeng ZHANG
Chinese Journal of General Surgery 2015;30(4):260-263
Objective To evaluate the feasibility and efficacy of ultrasound-guided popliteal vein catheter thrombolysis for acute deep venous thrombosis of the lower extremity.Methods Clinical data were retrospectively analyzed on 120 patients of unilateral acute lower extremity deep vein thrombosis from April 2010 to April 2013.60 cases were included in systemic thrombolytic group; 60 cases into catheter directed thrombolysis group.Thrombolysis rate and limb swelling reduction rate were calculated and compared between the two groups.Results Due to limb swelling rate,in systemic thrombolysis group:Thigh swelling reduction rate was (77 ± 9) % ; Leg swelling reduction rate was (70 ± 11) %,while in catheter directed thrombolys group,that was (87 ± 5) %,and (80 ± 9) %,respectively (P < 0.05).The thrombolysis rate in systemic group was (59 ± 14)%,that was (71 ± 13)% in catheter directed thrombolysis group (P < 0.05).Conclusions Ultrasound guided precutaneous catheter popliteal vein thrombolysis significantly improves the short-term outcome of deep venous thrombosis in terms of leg swelling reduction rate and thrombolysis reduction rate.